Phase II Study of bevacizumab plus either temozolomide or etoposide for (GBM) [glioblastoma] patients who have failed bevacizumab plus irinotecan

Trial Profile

Phase II Study of bevacizumab plus either temozolomide or etoposide for (GBM) [glioblastoma] patients who have failed bevacizumab plus irinotecan

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2014

At a glance

  • Drugs Bevacizumab (Primary) ; Etoposide (Primary) ; Temozolomide (Primary)
  • Indications Glioblastoma; Gliosarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 May 2008 Status change from initiated to in progress, according to clinicaltrials.gov.
    • 15 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top